Skip to main content
SpringerLink
Log in

Burden of ulcerative colitis substantial in Japan

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was sponsored by Janssen Pharmaceutical KK.

Reference

  • Miyazaki C, et al. Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis. Advances in Therapy : 30 Jan 2021. Available from: URL: http://doi.org/10.1007/s12325-020-01615-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burden of ulcerative colitis substantial in Japan. PharmacoEcon Outcomes News 872, 6 (2021). https://doi.org/10.1007/s40274-021-7479-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7479-4

Search

Navigation